Testing effectiveness (Phase 2)Study completedNCT02400463
What this trial is testing
A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome
Who this might be right for
Hemophagocytic Syndrome (HPS)
University of Michigan Rogel Cancer Center 6